CG Oncology, Inc. (CGON) vs Ligand Pharmaceuticals Incorporated (LGND)

• CG Oncology, Inc. CGON 59.79 ▼ −3.35%
• Ligand Pharmaceuticals Incorporated LGND 295.54 ▼ −0.99%

CG Oncology, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. CG Oncology, Inc. and Ligand Pharmaceuticals Incorporated are of similar size ($6.0B and $5.5B). CG Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 29.5×. CG Oncology, Inc. grew revenue faster over the last twelve months: 840.8% against 54.9%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs −3,602.7%) and the higher return on invested capital (8.19% vs −4,111.6%). Across the 17 metrics below, Ligand Pharmaceuticals Incorporated leads on 14 and CG Oncology, Inc. on 3.